EKF Diagnostics proposes acquisition of Selah Genomics and DiaSpect Medical
20th Mar 2014 11:10
EKF Diagnostics has entered into conditional agreements to buy US-based Selah Genomics and Swiss firm DiaSpect Medical. The company has proposed raising £22m through the placement of 14,285,714 new ordinary shares and a conditional placing of 48,571,428 new ordinary shares at a placing price of 35p
Read moreEKF Diagnostics acquires diagnostics business
12th Mar 2014 10:15
AIM-listed EKF Diagnostics Holdings, a point-of-care diagnostics business, has acquired Separation Technology, which manufactures in-vitro diagnostics (IVD) devices for the haematology testing market. The $4.0m (around £2.4m) cash consideration will be satisfied out of current debt facilities. The
Read moreMonday broker round-up
16th Sep 2013 12:13
AEC Education: WH Ireland places both its target price (prev.: 11p) and its recommendation under review. Aggreko: Citi reduces target price from 2100p to 2000p leaving its buy recommendation unaltered. Allergy Therapeutics: Panmure Gordon lowers target price from 18p to 16p, while keeping its buy
Read more